1. Home
  2. BCHT vs INCR Comparison

BCHT vs INCR Comparison

Compare BCHT & INCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCHT

Birchtech Corp. Common Stock

N/A

Current Price

$1.75

Market Cap

55.0M

Sector

Industrials

ML Signal

N/A

Logo Intercure Ltd.

INCR

Intercure Ltd.

HOLD

Current Price

$1.20

Market Cap

47.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BCHT
INCR
Founded
N/A
1994
Country
United States
Israel
Employees
15
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.0M
47.4M
IPO Year
2026
2021

Fundamental Metrics

Financial Performance
Metric
BCHT
INCR
Price
$1.75
$1.20
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
152.1K
20.2K
Earning Date
05-13-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.42
$69.54
Revenue Next Year
$61.22
$41.75
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.26
$0.68
52 Week High
$2.45
$1.77

Technical Indicators

Market Signals
Indicator
BCHT
INCR
Relative Strength Index (RSI) 58.18 80.31
Support Level $1.46 $0.72
Resistance Level $1.79 $1.68
Average True Range (ATR) 0.15 0.05
MACD 0.05 0.03
Stochastic Oscillator 79.31 92.86

Price Performance

Historical Comparison
BCHT
INCR

About BCHT Birchtech Corp. Common Stock

Birchtech Corp is a provider of specialty activated carbon technologies, delivering solutions for air and water purification. It provides patented and proprietary Sorbent Enhancement Additive (SEA) technologies for mercury emissions capture to the coal-fired utility sector, and is developing water purification technologies with a specialization on forever chemicals such as PFAS and PFOS. Geographically, the company derives all of its revenue from the United States.

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

Share on Social Networks: